Early rhythm-control therapy was associated with a lower risk of stroke in both the overall cohort and trial-eligible patients with recently diagnosed atrial fibrillation.
Does early rhythm-control therapy reduce the risk of stroke in patients with recently diagnosed atrial fibrillation?
Early rhythm-control therapy is associated with a lower risk of stroke in patients with recently diagnosed atrial fibrillation, supporting its adoption in clinical practice.
Absolute Event Rate: 0% vs 0%
=0.04]) patients for EAST-AFNET 4 trial inclusion. ERC was associated with lower risk of stroke in the overall cohort and in trial-eligible patients. Conclusions This analysis replicates the clinical benefit of ERC seen in EAST-AFNET 4. The results support adoption of ERC as part of the management of recently diagnosed AF in the United States.
Dickow et al. (Fri,) reported a other. Early rhythm-control therapy was associated with a lower risk of stroke in both the overall cohort and trial-eligible patients with recently diagnosed atrial fibrillation.